Cargando…

Ciclosporin/interferon-beta-1a: Various toxicities and off-label use: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732199/ http://dx.doi.org/10.1007/s40278-022-07868-0

Ejemplares similares

Ciclosporin: Various toxicities: case report
Publicado: (2022)

Ciclosporin/mycophenolate mofetil: Lack of efficacy and off-label use: case report
Publicado: (2022)

Dexamethasone/interferon-beta-1a/sulfasalazine: Toxic epidermal necrolysis and off label use: case report
Publicado: (2021)

Dexamethasone: Various toxicities and off-label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and no response to off-label therapy: case report
Publicado: (2021)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities and off-label use: case report
Publicado: (2020)

Tocilizumab: Various toxicities following an off-label use: 3 case reports
Publicado: (2020)

Multiple drugs: Various toxicities and off label use: 3 case reports
Publicado: (2020)

Hydroxychloroquine: Various toxicities secondary to off label use: 3 case reports
Publicado: (2020)

Tocilizumab: Various toxicities following off label use: 4 case reports
Publicado: (2021)

Anakinra: Various toxicities following off label use: 7 case reports
Publicado: (2021)

Multiple drugs: Various toxicities and off label use: 5 case reports
Publicado: (2021)

Multiple drugs: Various toxicities and off-label use: 10 case reports
Publicado: (2021)

Dexamethasone/methylprednisolone: Various toxicities following off label use: 21 case reports
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and lack of efficacy: case report
Publicado: (2022)

Multiple drugs: Various toxicities with lack of efficacy and off label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities, off-label use and lack of efficacy: case report
Publicado: (2020)

Azithromycin/chloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Chloroquine/hydroxychloroquine: Various toxicities following off label use: 3 case reports
Publicado: (2021)

Multiple drugs: Various toxicities, lack-of-efficacy and off-label use: case report
Publicado: (2021)

Ketamine: Various toxicities following off-label use of ketamine: 3 case reports
Publicado: (2021)

Baricitinib/hydroxychloroquine: Various toxicities secondary to off-label use: 4 case reports
Publicado: (2021)

Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020)

Azd-1222/interferon-beta-1a: Generalised morphoea and off-label use: 2 case reports
Publicado: (2022)

Multiple drugs: Lack of efficacy, and various toxicities due to off-label use: case report
Publicado: (2022)

Multiple drugs: Various toxicities, and lack of efficacy following off-label use: case report
Publicado: (2022)

Fluvoxamine/theophylline: Various toxicities following drug interaction and off-label use: case report
Publicado: (2022)

Methylprednisolone/tocilizumab: Various toxicities, off label use and lack of efficacy: 2 case reports
Publicado: (2022)

Deferasirox/hydroxychloroquine: Various toxicities and off-label use in coronavirus disease 2019: case report
Publicado: (2021)

Multiple drugs: Various toxicities following off-label use and lack-of-efficacy: case report
Publicado: (2021)

Lopinavir/ritonavir/ribavirin: Various toxicities following off-label treatment: case report
Publicado: (2020)

Multiple drugs: Various toxicities following interaction and off-label: 2 case reports
Publicado: (2020)

Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021)

Azithromycin/chloroquine: Various toxicities following off-label treatment: 2 case reports
Publicado: (2021)

Lopinavir/ritonavir: Various toxicities following off-label use in COVID-19: 4 case reports
Publicado: (2021)

Ciclosporin/prednisone: Visceral leishmaniasis: case report
Publicado: (2022)

Acitretin/ciclosporin: Treatment failure : case report
Publicado: (2021)

Dipyrone/interferon-β-1b interactions: Haematological toxicity following drug interactions and off-label use: case report
Publicado: (2021)

Abatacept/immunosuppressants/ruxolitinib: Various toxicities following off-label use and lack of efficacy: 20 case reports
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hl4459g8ncv2rqbidre6q3qsgr